Its capacity to lower the risk of cardiovascular diseases, improve blood pressure, and enhance cholesterol levels establishes Tirzepatide as a leading medication injection choice for weight loss in Scottsdale, AZ
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide.[1] That gap is not small, and for patients in Shreveport asking which medication is the better choice, this study provides the clearest evidence yet
Dose Timing and Gradual Increases to Minimize Nausea PlexusDx designs semaglutide therapy to start at a low dose and increase gradually over 412 weeks, giving your body time to adapt before moving to a higher strength
Vance CK, Vance H, Winter SC, et al
They do not dissolve clots but allow your body to do so over time
It belongs to glucagon-like peptide-1 receptor agonists (GLP-1 RAs)